XML 25 R16.htm IDEA: XBRL DOCUMENT
v3.22.2

Segment Reporting | 6 Months Ended
--- | ---
Jun. 30, 2022
Segment Reporting [Abstract] |
Segment Reporting | Segment Reporting The Company currently operates in two major lines of business that are also the Company's reportable operating segments - the operation of surgical facilities and the operation of ancillary services. The Surgical Facility Services segment consists of the operation of ASCs, surgical hospitals and anesthesia services. The Ancillary Services segment consists of multi-specialty physician practices. The "All other" line item primarily consists of the Company's corporate general and administrative functions. The following tables present financial information for each reportable segment (in millions):
|  | Three Months Ended June 30, |  | Six Months Ended June 30,
|  | 2022 |  | 2021 |  | 2022 |  | 2021
Revenues: |  |  |  |  |  |  |  |
Surgical Facility Services |  | $ | 597.9 |  |  | $ | 525.8 |  |  | $ | 1,176.7 |  |  | $ | 1,021.6 |
Ancillary Services |  | 17.5 |  |  | 17.5 |  |  | 34.9 |  |  | 34.1 |
Total |  | $ | 615.4 |  |  | $ | 543.3 |  |  | $ | 1,211.6 |  |  | $ | 1,055.7 |
Adjusted EBITDA: |  |  |  |  |  |  |  |
Surgical Facility Services |  | $ | 108.7 |  |  | $ | 95.6 |  |  | $ | 209.7 |  |  | $ | 190.6 |
Ancillary Services |  | (0.8) |  |  | (0.1) |  |  | (0.7) |  |  | (1.0) |
All other |  | (21.8) |  |  | (19.6) |  |  | (45.8) |  |  | (40.8) |
Total |  | $ | 86.1 |  |  | $ | 75.9 |  |  | $ | 163.2 |  |  | $ | 148.8 |
Reconciliation of Adjusted EBITDA: |  |  |  |  |  |  |  |
Income before income taxes |  | $ | 19.6 |  |  | $ | 6.1 |  |  | $ | 63.7 |  |  | $ | 17.1 |
Net income attributable to non-controlling interests |  | (33.7) |  |  | (35.7) |  |  | (64.3) |  |  | (67.5) |
Depreciation and amortization |  | 28.0 |  |  | 25.2 |  |  | 55.4 |  |  | 50.9 |
Interest expense, net |  | 56.9 |  |  | 53.4 |  |  | 113.2 |  |  | 106.7 |
Equity-based compensation expense |  | 4.3 |  |  | 4.1 |  |  | 8.0 |  |  | 9.3 |
Transaction, integration and acquisition costs (1) |  | 8.2 |  |  | 11.4 |  |  | 15.3 |  |  | 20.8 |
Loss on disposals and deconsolidations, net |  | 1.1 |  |  | 1.0 |  |  | 1.0 |  |  | 0.1 |
Loss (gain) on litigation settlement and other litigation costs (2) |  | 1.7 |  |  | 0.8 |  |  | (29.1) |  |  | 1.8 |
Loss on debt extinguishment |  | — |  |  | 9.6 |  |  | — |  |  | 9.6 |
Adjusted EBITDA |  | $ | 86.1 |  |  | $ | 75.9 |  |  | $ | 163.2 |  |  | $ | 148.8 |
(1)This amount includes transaction and integration costs of $8.2 million and $9.2 million for the three months ended June 30, 2022 and 2021, respectively. This amount further includes start-up costs related to a de novo surgical hospital of $2.2 million for the three months ended June 30, 2021. This amount includes transaction and integration costs of $15.3 million and $14.5 million for the six months ended June 30, 2022 and 2021, respectively. This amount further includes start-up costs related to a de novo surgical hospital of $6.3 million for the six months ended June 30, 2021. (2)This amount includes other litigation costs of $1.7 million and $0.8 million for the three months ended June 30, 2022 and 2021, respectively. This amount includes other litigation costs of $3.7 million and $1.8 million for the six months ended June 30, 2022 and 2021, respectively. This amount also includes gain on litigation settlement of $32.8 million for the six months ended June 30, 2022.
|  | June 30, 2022 |  | December 31, 2021
Assets: |  |  |  |
Surgical Facility Services |  | $ | 5,691.3 |  |  | $ | 5,552.8 |
Ancillary Services |  | 44.5 |  |  | 47.5 |
All other |  | 555.8 |  |  | 517.3 |
Total assets |  | $ | 6,291.6 |  |  | $ | 6,117.6 |
|  | Six Months Ended June 30,
|  | 2022 |  | 2021
Cash purchases of property and equipment: |  |  |  |
Surgical Facility Services |  | $ | 36.9 |  |  | $ | 27.2 |
Ancillary Services |  | 0.5 |  |  | 0.2 |
All other |  | 3.2 |  |  | 0.6 |
Total cash purchases of property and equipment |  | $ | 40.6 |  |  | $ | 28.0 |

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 34 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 40 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (f) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (e) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 26 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (d) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 42 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 15 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -URI https://asc.fasb.org/topic&trid=2134510 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration